A Study in Subjects With Retinitis Pigmentosa

Clinical trial NCT05392179 · COMPLETED

Trial details

NCT number: NCT05392179
Sponsor: Aldeyra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2022-07-14
Primary completion: 2023-06-23
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.